SCANDION ONC. DK-0735
Scandion Oncology A/S, a clinical-stage biotechnology company, develops medicines for the treatment of cancer. Its lead product candidate is the SCO-101, an oral drug that is in Phase IIa clinical trial for the treatment of drug resistant metastatic colorectal cancer; and in Phase Ib clinical trial for treating unresectable or metastatic pancreatic cancer, as well as in preclinical studies for tr… Read more
Market Cap & Net Worth: SCANDION ONC. DK-0735 (8VY)
SCANDION ONC. DK-0735 (F:8VY) has a market capitalization of $144.59K (€140.86K) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #40195 globally and #5847 in its home market, demonstrating a 50.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SCANDION ONC. DK-0735's stock price €0.00 by its total outstanding shares 234762000 (234.76 Million).
SCANDION ONC. DK-0735 Market Cap History: 2021 to 2025
SCANDION ONC. DK-0735's market capitalization history from 2021 to 2025. Data shows change from $285.80 Million to $144.59K (-83.46% CAGR).
SCANDION ONC. DK-0735 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SCANDION ONC. DK-0735's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 8VY by Market Capitalization
Companies near SCANDION ONC. DK-0735 in the global market cap rankings as of March 19, 2026.
Key companies related to SCANDION ONC. DK-0735 by market ranking:
- Danske Invest - Nye Markeder Obligationer (CO:DKINMOBL): Ranked #40186 globally with a market cap of $144.18K USD ( Dkr1.05 Million DKK).
- Crookes Brothers Ltd (JSE:CKS): Ranked #40187 globally with a market cap of $144.18K USD ( ZAC271.30 Million ZAC).
- Photomyne Ltd (TA:PHTM): Ranked #40196 globally with a market cap of $143.33K USD ( ILA53.46 Million ILA).
- APT Systems Inc (PINK:APTY): Ranked #40197 globally with a market cap of $143.25K USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #40186 | Danske Invest - Nye Markeder Obligationer | CO:DKINMOBL | $144.18K | Dkr106.01 |
| #40187 | Crookes Brothers Ltd | JSE:CKS | $144.18K | ZAC1801.00 |
| #40196 | Photomyne Ltd | TA:PHTM | $143.33K | ILA2244.00 |
| #40197 | APT Systems Inc | PINK:APTY | $143.25K | $0.00 |
SCANDION ONC. DK-0735 Historical Marketcap From 2021 to 2025
Between 2021 and today, SCANDION ONC. DK-0735's market cap moved from $285.80 Million to $ 144.59K, with a yearly change of -83.46%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €144.59K | -90.91% |
| 2024 | €1.59 Million | -97.93% |
| 2023 | €76.75 Million | +61.68% |
| 2022 | €47.47 Million | -83.39% |
| 2021 | €285.80 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of SCANDION ONC. DK-0735 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $144.59K USD |
| MoneyControl | $144.59K USD |
| MarketWatch | $144.59K USD |
| marketcap.company | $144.59K USD |
| Reuters | $144.59K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.